This study aimed to elucidate mechanism (s) 
INTRODUCTION
Dopamine (DA) is an endogenous catecholamine that serves not only as a precursor for norepinephrine and epinephrine but also as a neurotransmitter.
Dopamine is involved in a wide variety of physiological processes both in central nervous system (CNS) and in peripheral tissues and organs (1) . In the mammalian brain, DA controls a variety of functions including locomotors activity, cognition, food intake and endocrine regulation. This catecholamine also plays multiple roles in the periphery as a modulator of cardiovascular functions (CVS), catecholamine release, hormone secretions, vascular tone, renal functions and gastrointestinal motilities (2) . Dopamine exerts its physiological actions via -and -adrenergic receptors as well as via specific dopaminergic receptors, a class of cell surface receptors coupled to Gproteins. Dopaminergic 4 ) and linked to inhibition of adenyl cyclase (2) . All the mammalian dopamine receptors initially cloned from the brain, have been found to be expressed outside CNS, in such sites as the heart, blood vessels, carotid body, kidney, adrenal gland, parathyroid gland, gastrointestinal tract, vascular smooth muscle, and on the terminals of postganglionic sympathetic nerves (4, 5, 6) . It is evident from forgoing studies on the multiple dopamine receptors that activation and /or blockade of them can lead to pronounced changes in cardiovascular functions. Indeed, rodents with genetic hypertension and human with essential hypertension are associated with a defective dopamine production and/or dopamine receptor functions (2, 7) . Moreover, dopamine receptor blockade is associated with the development of hypertension in saline-loaded rats. Finally, inhibition of dopamine synthesis outside CNS accelerates hypertension development in spontaneously hypertensive rats (8) . The present study was designed to determine the possible receptor subtype(s) which mediate the effect of dopamine in regulation of some cardiovascular functions as arterial blood pressure (ABP), heart rate (HR) and cardiac contractility (CC). Also, to study the possible association between dopamine and sympathetic nervous system on affecting cardiovascular functions.
MATERIALS & METHODS

Animals.
This investigation was carried out on 48 adult male Balady rabbits, weighing (1.2 -1.5 kg) divided into 8 groups, 6 animals each. On arrival, animals were caged individually in room temperature with natural lightdark cycle with free access to water and commercial rabbit food. This study was carried out on 4 experiments at the same period each day (8-10 am The surgical technique was done according to steps described by Muhlbauer et al. (9) . Rabbits were anesthetized through intraperitoneal (ip) injection of urethane (600 mg/kg). The trachea was exposed by blunt dissection and intubated with a short cannula to insure free airways during experiments. One catheter was inserted into right jugular vein for iv infusion of the drugs via its connection to the syringe pump (ColeParmer, 74900-00-05, Cole-Parmer Instrument Company, USA) and another catheter into left common carotid artery for ABP recording and blood sampling. Heparin (0.25 ml) was injected iv through the catheter to prevent intracatheter clotting. Following surgical preparation, animals were allowed to reach steady state condition defined by stable ABP and HR which achieved within 15 min.
Study protocol.
In Experiment I, two groups of rabbits (Groups 1 and 2) were used. After the steady state conditions reached, a baseline period (control) of 30 min was performed. During the control period the animals received iv infusion of 0.9 % sterile sodium chloride solution (vehicle) at a rate of 0.02 ml/min delivering approximately 0.6 ml solution throughout the experiment. After completion of baseline period, infusion was switched to dopamine in 4 doses. Group (1) received iv infusion of dopamine at a rate of 0.1 and 1 µg/kg/min with 15 min interval delivering approximately 0.6 ml (0.02 ml/min) throughout the experiment for each dose. Group (2) received iv infusion of dopamine at a rate of 4 and 12 µg/kg/min with 15 min interval delivering approximately 0.6 ml (0.02 ml/min) throughout the experiment for each dose. Arterial BP, HR and CC were recorded before (baseline), at 1, 15 and 30 min during dopamine infusion (experimental period) and at 15 min after termination of infusion (recovery period). Renal sympathetic nerve activity (RSNA) was recorded before (baseline) and at 30 min during dopamine infusion at rates of 1 and 12 μg/kg/min (preferred effective low and high doses respectively).
In experiment II, 3 groups of rabbits (Groups 3-5) were used. Group 3 (control group) received iv infusion of normal saline at a rate of 0.02 ml/min for 30 min; groups (4 and 5) received iv infusion of dopamine at a rate of 1 and 12 μg/kg/min for 30 min successively. After infusion termination, specimens from left ventricle were taken and prepared for electro-microscopic examination. Sarcomere length (μm) and ratio of A: I band were measured.
In experiment III, two groups (6 and 7) of rabbits were used. Animals of group (6) received iv infusion of SKF-3839 (5 μg/kg/min for 15 min), a selective agonist of D 1 -like receptor (10) . After a rest period of 15 min, the same animals received iv infusion of 1μg/kg/min dopamine 20 min after a previous administration of SCH-23390 (50 μg/kg, ip), a selective antagonist of D 1 -like receptor (11) . After an additional 15 min rest period, rabbits received iv infusion of 12 µg/kg/min dopamine 20 min after previous administration of SCH-23390 (50 μg/kg, ip). Animals of group (7) . The amplitude of bursts (mm) and frequency (rate/min) were used as an index of sympathetic nerve activity. Samples from ventricular tissues of the rabbits were prepared for electro-microscopic examination.
Statistical analysis.
The statistical analysis was performed using Prism software version 3. Data were expressed as mean +/-standard error (SE). For inter-group comparison, analysis with two-sided paired Student's "t" test or one way ANOVA test was carried out as appropriate. Differences between results were considered statistically significant when P-value was less than 0.05.
RESULTS
Tables (1) and Figures (1 and 2 ) summarize the effect of intravenous dopamine infusion (0.1, 1, 4 and 12 µg/kg/min) on ABP (mmHg), HR (beat/min) and CC (mm) respectively in adult male rabbits. From these tables it is clear that at dose 1 µg/kg/min, a significant decrease was observed in DBP (P <0.05, P <0.01 and P <0.01) and MBP (P <0.05, P <0.001 and P <0.001) compared with baseline level at 1, 15 and 30 min during infusion respectively. While, at dose 12 µg/kg/min, a significant increase was observed in DBP (P <0.05), SBP (P <0.01), and MBP (P <0.01, P <0.001 and P <0.001) compared with baseline level at 1, 15 and 30 min during infusion successively.
Heart rate was significantly increased at 15 and 30 min during iv dopamine infusion at doses of 4 µg/kg/min (P <0.05) and 12 µg/kg/min (P <0.05) ( Table 2 ; Figures  1 and 2 ). Cardiac contractility at 1, 15 and 30 min during dopamine infusion showed a significant decrease with a dose of 1 µg/kg/min (P <0.05, P <0.01 and P <0.01 respectively) but a significant increase was observed with a dose of 12 µg/kg/min (P <0.05, P <0.01 and P <0.01 successively). Whereas, at a dose of 4 µg/kg/min, a significant increase in CC was observed at 15 and 30 min only (P <0.05) ( Table 3 ; Figures 1 and 2 ).
Intravenous infusion of dopamine at a dose of 1 µg/kg/min led to a significant decrease in frequency and amplitude (P <0.001) of RSNA and a significant increase in sarcomere length and A:I ratio (P <0.01). While, iv infusion of dopamine at a dose of 12 µg/kg/min led a to decrease in sarcomere length and A:I ratio (P <0.05) ( Table 4 , Figures 3-6 ).
Activation of D 1 -like receptor by intravenous SKF-38393 infusion resulted in a significant decrease in MBP (P <0.01). Whereas, activation of D 2 receptors by iv bromocriptine infusion resulted in a significant decrease in MBP, CC and frequency and amplitude of RSNA (P <0.05, P <0.01, P <0.001 and P <0.001 respectively) ( Table 5) .
Administration of D 1 -like antagonist SCH-23390 alone didn't cause any significant change in the levels of MBP, HR and CC compared with baseline levels. Intravenous dopamine infusion after SCH-23390 pre-treatment at a dose of 1μg/kg/min led to a significant decrease in the MBP and CC (P <0.05, P <0.01), meanwhile, at dose 12 μg/kg/min led to significant increase in MBP, HR and CC (P <0.01, P <0.05 and P <0.01 successively) compared to control level. Administration of D 2 -like receptor antagonist metoclopramide alone didn't cause any significant change in the levels of MBP, HR and CC compared with baseline levels. Intravenous dopamine infusion after metoclopramide pretreatment led to a significant decrease in the MBP (P <0.05), while, 12 μg/kg/min led to a significant increase in the MBP, HR and CC (P <0.01) compared to control level (Table 6) .
After reserpine pre-treatment, iv dopamine infusion at a rate of 1 µg/kg/min led to a significant decreased in MBP and CC (P <0.05 and P <0.01 respectively), while at dose of 12 µg/kg/min led to significant increased in HR and CC (P <0.05, P <0.01 successively) compared with the pre-injected dopamine (control) levels and after propranolol pre-treatment, iv dopamine infusion at a rate of 1 µg/kg/min led to a significant decreased in MBP and CC (P <0.01), while at a dose of 12 µg/kg/min led to significant increase in MBP (P <0.05) compared to control level (Table 7 ).
Figure (1):
Recording of arterial blood pressure (A), heart rate (B) and cardiac contractility (C) responses to intravenous dopamine infusion at a rate of 1 g/kg/min in adult male rabbits.
Figure (2):
Recording of arterial blood pressure (A), heart rate (B) and cardiac contractility (C) responses to intravenous dopamine infusion at a rate of 12 g/kg/min in adult male rabbits. 
DISCUSSION
The pharmacological effects of dopamine are unique sequence of receptor activation and dose dependent. The observations of the present study demonstrated that dopamine elicits biphasic effect on ABP and CC. At low infusion rates of dopamine (1 µg/kg/min), MBP and CC were decreased, whereas at high infusion rates (12 µg/kg/min), MBP, HR and CC were increased. The effect of dopamine infusion was apparent immediately and gradually (by 1 min), maximal change was seen during the first 15 min of infusion and tended to return to the baseline levels by the end of infusion. Thus the effects of dopamine occur only during the infusion periods. With dose of 1µg/kg/min of dopamine infusion, the depressor effect resulted mainly from decrease in the diastolic blood pressure, whereas the pressor effect seen with a dose of 12 μg/kg/min caused by elevations of both diastolic and systolic blood pressure.
A decrease in MBP in the absence of changes in HR as observed after dopamine at low infusion rate (1μg/kg/min) in the present study suggests a vasodilatation. The cardiovascular effects of exogenously administered dopamine in different animals and human were investigated sparsely. Dobrowolski et al. In an attempt to investigate the interaction between dopamine and sympathetic nervous system, 12 μg/kg/min dopamine infusion resulted in an increase in RSNA. In addition, a chemical denervation of the sympathetic nerve terminals was made by a pre-treatment of the animals with reserpine and propranolol. This experiment revealed that dopamine infusion at high rate (12 μg/kg/min) into animals after reserpine caused increase in HR and CC and after propranolol caused increase in MBP when compared with pre-injected dopamine level (control level). These results collectively suggest that vascular and cardiac actions of higher dose of dopamine are mediated by the activation of α and β-adrenoceptors. The arterial blood pressure effect is α-adrenergic dependant, whereas HR and CC was β-adrenergic dependant. These results are in agreement with Olsen (19) who reported that with increasing doses of dopamine (at and above 7.5 µg/kg/min), the renal blood flow was decreasing. Furukawa et al.
(41) found that in dogs, improvement in hemodynamics indicated by marked increase in cardiac blood flow, cardiac output and mean arterial blood pressure was observed at higher doses of dopamine (10 and 20 μg/kg/min). Meneton (42) stated that at higher concentrations of dopamine, α-and β-adrenergic receptors are occupied. Jasiñska et al.
(43) found that dopamine infusion at 10 μg/min/kg improved myocardial contractility in rabbits. Recently, Wakita (44) observed that administration of dopamine into the perfusate of the isolated rabbit heart at doses of 100 to 1000 μg was found to produce dose-related increases in contractile activities and heart rates in the normal preparation, and this effect was greatly suppressed in the denervated preparations, suggesting that the primary chronotropic and inotropic effect of dopamine is an indirect one via norepinephrine release of from sympathetic nerve terminals.
It is evident from the forgoing discussion on multiple dopamine receptors that activation and /or blockade of these receptors can lead to pronounced changes in cardiovascular functions. Therefore, an obvious question that can be asked is whether sufficient quantities of endogenous dopamine are available to act on these receptors and thereby play a physiological role in control of cardiovascular function. In the present study, D 1 -like receptor antagonist SCH-23390 and D 2 -like receptor antagonist metoclopramide were used to investigate the interaction between endogenous dopamine and ABP, HR and CC in normal rabbits. Blockade of either D 1 -like receptor by SCH-23390 or D 2 -like receptors by metoclopramide alone has no effect on baseline levels of MBP, HR and CC. Furthermore, iv dopamine infusion alone at low rate (1 μg/kg/min) decreased significantly MBP and CC, whereas change in HR wasn't significantly altered. These data suggest that under basal conditions endogenous, dopamine may not alter the basal cardiac and vascular functions. There is no physiological activation of cardiovascular dopaminergic receptors in rabbits. Oliva et al. claimed that microinjection of dopamine into the caudal nucleus tractus solitarii does not affect either the autonomic activity to the cardiovascular system or the autonomic and respiratory responses of chemoreflex activation in awaken rats.
There are two possible sources of endogenous dopamine which can activate these receptors. Circulating dopamine and dopamine containing neurons in close proximity to these receptors. Levels of circulating dopamine have been measured accurately in various animals and humans. The levels of free dopamine in plasma are too low to exert any significant effect. The affinity of dopamine to its receptors is in the nanomolar range. Circulating concentrations of dopamine (picomolar range) are not sufficiently high to activate dopamine receptors, while in dopamine producing tissues concentrations in the high nanomolar to micromolar range can be attained (4) . Circulating dopamine reportedly synthesized in neural and non neural tissues (4) . In conclusion. 
